Ovoca Bio | OVG - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
ALKERMES USD 165.61M 503K 2025-12
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Great Western Mining Corporation EUR 457.75K 100K 2023-06
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Malin Corporation EUR 200K 0 2024-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Ovoca Bio EUR 11.06M 0 2022-06
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09